Interleukin-2 (IL-2) and IL-15 are structurally related cytokines that share receptor components but display markedly different effects in multiple in vivo model systems. Here we demonstrate that IL-15 but not IL-2 exacerbates xenogeneic graft-versus-host disease (X-GVHD) in severe combined immunodeficient murine recipients of human peripheral-blood lymphocytes (hu-PBL-SCID). Treatment of hu-PBL-SCID mice with IL-15 resulted in rapid fatality, lymphocytic infiltrations in the liver, lung, and spleen consistent with X-GVHD, and a marked expansion of human CD4+ and CD8+ T cells compared with controls. Depletion of human T cells in vivo abrogated the lethality of IL-15 treatment. To our knowledge, these data are the first to demonstrate in vivo activation and expansion of human T lymphocytes in response to IL-15 with concomitant exacerbation of human T-cell-mediated X-GVHD. © 2005 by The American Society of Hematology.
CITATION STYLE
Roychowdhury, S., Blaser, B. W., Freud, A. G., Katz, K., Bhatt, D., Ferketich, A. K., … Caligiuri, M. A. (2005). IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood, 106(7), 2433–2435. https://doi.org/10.1182/blood-2005-04-1597
Mendeley helps you to discover research relevant for your work.